Investing.com - Avid Bioservices reported on Tuesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Avid Bioservices announced earnings per share of $-0.01 on revenue of $34.76M. Analysts polled by Investing.com anticipated EPS of $0.01 on revenue of $32.05M.
Avid Bioservices shares are down 49% from the beginning of the year , still down 52.02% from its 52 week high of $31.01 set on Tuesday, December 28, 2021.
Avid Bioservices follows other major Healthcare sector earnings this month
Avid Bioservices's report follows an earnings beat by AstraZeneca ADR on Thursday, November 10, 2022, who reported EPS of $1.67 on revenue of $10.98B, compared to forecasts EPS of $0.77 on revenue of $10.78B.
Medtronic had beat expectations on Tuesday, November 22, 2022 with second quarter EPS of $1.3 on revenue of $7.6B, compared to forecast for EPS of $1.28 on revenue of $7.7B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar